While this supports weight loss, it can also slow bowel movements
Ro brings all that together into one streamlined app, from your first provider consult and lab work to prescriptions, insurance support, and even coaching
Among patients who do fill their first script, an additional 36% discontinue after just one fill, a phenomenon known as "one & done" or non-persistent patient behavior
"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." Press release
For indexed literature and PubMed research on Retatrutide signaling, consult PubMed Retatrutide Citations
Adjusted for placebo, the weight loss was 26.6%, according to BMO